Innovation Pharmaceuticals Inc (IPIX)

[sox040713]

I did not say IPIX cannot apply for EUA after Phase 2. What I meant was what advantage does IPIX have over Pfizer to bypass Phase 3. Is it based on data of the 60 patients who received B (possibly without statistical significance), or is it because IPIX is a penny stock and not in the FDA's pocket?

Can you point to a rule or regulation where you need a minimum number of patients to get an EUA?